Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li>Organovo is a biotech company that has 3D technology enabling the company to produce various human tissues, allowing the company to target diseases and accelerate the drug development process.</li><li> The company recently released positive Phase 2 results for one of its primary treatments-FXR314.</li><li>These results are very encouraging and bolsters our belief in the future prospects for ONVO. </li></ul>

Organovo is a biotech company that has 3D technology enabling the company to produce various human tissues, allowing the company to target diseases and accelerate the drug development process. The company recently released positive Phase 2 results for one of its primary treatments-FXR314.These results are very encouraging and bolsters our belief in the future prospects for ONVO. 

ONVO:  Positive Phase 2 Results Bolsters Outlook

Organovo Holdings

ONVO: Positive Phase 2 Results Bolsters Outlook